Jacob Siegel, MD

Assistant Professor in Dermatology

DownloadHi-Res Photo

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Additional Titles

Director of Wellness, Dermatology

Contact Info

jacob.siegel@yale.edu

About

Titles

Assistant Professor in Dermatology

Director of Wellness, Dermatology

Appointments

Dermatology
Assistant Professor
Primary
Dermatology

Education & Training

Chief Resident: Yale New Haven Hospital

Resident: Yale New Haven Hospital

Intern: Memorial Sloan Kettering Cancer Center

MD: Yale School of Medicine

BA: Yale College

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of Jacob Siegel's published research.

Amanda Zubek, MD, PhD, FAAD
View Full Profile
View 2 Common Publications
Francine Foss, MD
View Full Profile
View 2 Common Publications
Leonard Milstone, MD
View Full Profile
View 2 Common Publications
Aarti Bhatia, MD, MPH
View Full Profile
View Common Publication
Christine Ko, MD
View Full Profile
View Common Publication
Jonathan Leventhal, MD
View Full Profile
View Common Publication

Publications

2024

Using Shame as a Signal to Talk about Suicide
Siegel J, Ko C. Using Shame as a Signal to Talk about Suicide. Clinical Chemistry 2024, 70: 786-788. PMID: 38441566, DOI: 10.1093/clinchem/hvae017.
Peer-Reviewed Original Research
MeSH Keywords

2021

Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
Siegel JD, Bhatia A, Ko CJ, Christensen SR. Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab. JAAD Case Reports 2021, 18: 23-25. PMID: 34778502, PMCID: PMC8577130, DOI: 10.1016/j.jdcr.2021.10.009.
Peer-Reviewed Original Research
Concepts

2020

Development or worsening of sarcoidosis associated with IL‐17 blockade for psoriasis
Hornick N, Wang A, Lim Y, Gehlhausen J, Siegel J, Wang J, Foss F, Lim I, Zubek A, Milstone L, Galan A, King B, Damsky W. Development or worsening of sarcoidosis associated with IL‐17 blockade for psoriasis. Journal Of The European Academy Of Dermatology And Venereology 2020, 34: e583-e585. PMID: 32277505, DOI: 10.1111/jdv.16451.
Peer-Reviewed Case Reports and Technical Notes
MeSH Keywords
Interleukin‐17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis
Wang A, Hornick N, Lim Y, Gehlhausen J, Siegel J, Wang J, Foss F, Lim I, Zubek A, Milstone L, Galan A, King B, Damsky W. Interleukin‐17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis. Journal Of The European Academy Of Dermatology And Venereology 2020, 34: e497-e499. PMID: 32249470, DOI: 10.1111/jdv.16416.
Peer-Reviewed Case Reports and Technical Notes
MeSH Keywords

2018

Bullous disorders associated with anti–PD-1 and anti–PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy
Siegel J, Totonchy M, Damsky W, Berk-Krauss J, Castiglione F, Sznol M, Petrylak DP, Fischbach N, Goldberg SB, Decker RH, Stamatouli AM, Hafez N, Glusac EJ, Tomayko MM, Leventhal JS. Bullous disorders associated with anti–PD-1 and anti–PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy. Journal Of The American Academy Of Dermatology 2018, 79: 1081-1088. PMID: 30025829, DOI: 10.1016/j.jaad.2018.07.008.
Peer-Reviewed Original Research
MeSH Keywords and Concepts

Academic Achievements & Community Involvement

activity
American Academy of Dermatology
Professional OrganizationsFellow
Details
honor
Rising Star
National AwardCastle Connolly
Details
honor
Book Award
Regional AwardNew England Deramtological Society
Details
honor
Miriam Kathleen Dasey Award
Yale School of Medicine AwardYale School of Medicine
Details

Clinical Care

Overview

Jacob Siegel, MD, specializes in treating skin disorders, including keloids, sebaceous cysts, acne, folliculitis, and milia. He provides Botox injections for both cosmetic and medical purposes.

In addition to his clinical work, Dr. Siegel’s research interests include the relationship between treatments for psoriasis and the development of sarcoidosis, and the impact of specialized cancer therapies on the development of bullous disorders.

In recognition of his work, Dr. Siegel has received the Book Award and the Miriam Kathleen Dasey Award. He is an assistant professor of dermatology at Yale University School of Medicine.

Dermatology

Fact Sheets

Cancer Screening
Learn More on Yale Medicine
Botox and Soft Tissue Fillers
Learn More on Yale Medicine
Rosacea
Learn More on Yale Medicine
Cancer
Learn More on Yale Medicine

See All Fact Sheets On Yale Medicine

Board Certifications

Dermatology
Certification Organization
AB of Dermatology
Original Certification Date
2021

Yale Medicine News

See All News On Yale Medicine

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

News

April 29, 2024
Conn. hospital provides free skin cancer screenings for firefighters
Source: The Day
Read moreabout Conn. hospital provides free skin cancer screenings for firefighters

Get In Touch

Contacts

jacob.siegel@yale.edu

Appointment Number

203.481.3419

Locations

Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
See Patient Care Locations

Are You a Patient?

Additional Titles

Contact Info

Titles

Appointments

Dermatology

Other Departments & Organizations

Education & Training

Research at a Glance

Yale Co-Authors

Amanda Zubek, MD, PhD, FAAD

Francine Foss, MD

Leonard Milstone, MD

Aarti Bhatia, MD, MPH

Christine Ko, MD

Jonathan Leventhal, MD

Publications

2024

Using Shame as a Signal to Talk about Suicide

2021

Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab

2020

Development or worsening of sarcoidosis associated with IL‐17 blockade for psoriasis

Interleukin‐17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis

2018

Bullous disorders associated with anti–PD-1 and anti–PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy

American Academy of Dermatology

Rising Star

Book Award

Miriam Kathleen Dasey Award

Overview

Clinical Specialties

Fact Sheets

Cancer Screening

Botox and Soft Tissue Fillers

Rosacea

Cancer

Board Certifications

Dermatology

Yale Medicine News

Quick Chat About Skin Cancer with Yale Dermatologist Sean Christensen

9 Ways to Lower Skin Cancer Risk

Are You a Patient?

News

Conn. hospital provides free skin cancer screenings for firefighters

Contacts

Locations

Patient Care Locations